Literature DB >> 27716918

Commode Cardia-Death by Valsalva Maneuver: A Case Series.

Amanda O Fisher-Hubbard1, Kilak Kesha1,2, Francisco Diaz1,2, Chantel Njiwaji1,2, PaoLin Chi3, Carl J Schmidt1,2.   

Abstract

The Valsalva maneuver is used in clinical medicine for the diagnosis and/or treatment of various cardiovascular conditions. It can also be used in activities of daily living, such as defecation. Due to the cardiovascular effects produced during the Valsalva maneuver, it may be contraindicated in certain medical conditions and could be a trigger of sudden cardiac death. The incidence and prevalence of death following Valsalva maneuver in the presence of underlying cardiovascular disease, or "commode cardia," has not been examined. In 2012, the Wayne County Medical Examiner's Office (Detroit, MI) investigated 21 deaths that occurred on the toilet, fourteen of which were due to cardiovascular disease. In another 31 deaths in the bathroom due to cardiovascular disease, the possibility that the decedent defecated immediately prior to death could not be excluded. Hence, the incidence of commode cardia in this population ranges from 2.3 to 7.4% of all cardiovascular-related deaths.
© 2016 American Academy of Forensic Sciences.

Entities:  

Keywords:  Valsalva maneuver; cardiovascular disease; commode cardia; forensic pathology; forensic science; sudden cardiac death; vagal maneuver

Mesh:

Year:  2016        PMID: 27716918     DOI: 10.1111/1556-4029.13196

Source DB:  PubMed          Journal:  J Forensic Sci        ISSN: 0022-1198            Impact factor:   1.832


  2 in total

1.  Unusual Cause of Cardiac Arrest.

Authors:  Takahiro Tsushima; Toral R Patel; Jayakumar Sahadevan
Journal:  JAMA Intern Med       Date:  2021-04-01       Impact factor: 44.409

2.  Cardiovascular fingolimod effects on rapid baroreceptor unloading are counterbalanced by baroreflex resetting.

Authors:  Max J Hilz; Sankanika Roy; Carmen de Rojas Leal; Mao Liu; Francesca Canavese; Klemens Winder; Katharina M Hoesl; De-Hyung Lee; Ralf A Linker; Ruihao Wang
Journal:  Neurol Sci       Date:  2021-01-14       Impact factor: 3.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.